PI3K inhibition sensitize cancer cells to tumor treating fields (TTFields)

被引：0
|
作者：
Klein-Goldberg, Anat
Voloshin, Tali
Zemer-Tov, Efrat
Paz, Rom
Koren, Lilach
Wainer-Katsir, Kerem
Volodin, Alexandra
Koltun, Bella
Brant, Boris
Barsheshet, Yiftah
Kan, Tal
David, Cfir
Khalil, Tharwat Haj
Haber, Adi
Giladi, Moshe
Weinberg, Uri
Palti, Yoram
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4860
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4860
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Effects of tumor treating fields (TTFields) with FOLFIRINOX on BRCA WT pancreatic cancer cells.
    Zheng, Michael
    Ene, Hila
    Ben Meir, Kerem
    Gabay, Hila
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Palti, Yoram
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 753 - 753
  • [32] Immunomodulatory effects of Tumor Treating Fields (TTFields) on lung cancer models
    Weinberg, U.
    Kaynan, N.
    Sela, T. Voloshin
    Davidi, S.
    Porat, Y.
    Shteingauz, A.
    Munster, M.
    Schneiderman, R. S.
    Brami, C. Tempel
    Zeevi, E.
    Gotlib, K.
    Cahal, S.
    Giladi, M.
    Kirson, E.
    Kinzel, A.
    Palti, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment
    Vergote, Ignace
    Macarulla, Teresa
    Hirsch, Fred R.
    Hagemann, Carsten
    Miller, David Scott
    CANCERS, 2023, 15 (03)
  • [34] Tumor treating fields (TTFields) induce cancer cell permeability in vitro
    Voloshin, Tali
    Porat, Yaara
    Kaynan, Noa
    Klein-Goldberg, Anat
    Paz, Rom
    Volodin, Alexandra
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2020, 80 (16)
  • [35] Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells
    Strack, Maren
    Kueckelhaus, Jan
    Diebold, Martin
    Wuchter, Patrick
    Huber, Peter E.
    Schnell, Oliver
    Sankowski, Roman
    Prinz, Marco
    Grosu, Anca-Ligia
    Heiland, Dieter Henrik
    Nicolay, Nils H.
    Ruehle, Alexander
    JOURNAL OF NEURO-ONCOLOGY, 2024, 169 (02) : 329 - 340
  • [36] Immunomodulatory effects of tumor treating fields (TTFields) on colon cancer models
    Voloshin, Tali
    Kaynan, Noa
    Davidi, Shiri
    Porat, Yaara
    Shteingauz, Anna
    Munster, Mijal
    Schneiderman, Rosa S.
    Tempel-Brami, Catherine
    Zeevi, Einav
    Gotlib, Karnit
    Cahal, Shay
    Giladi, Moshe
    Kirson, Eilon D.
    Weinberg, Uri
    Kinzel, Adrian
    Palti, Yoram
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [37] Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations
    Rittler, Dominika
    Molnar, Eszter
    Baranyi, Marcell
    Garay, Tamas
    Hegedus, Luca
    Aigner, Clemens
    Tovari, Jozsef
    Timar, Jozsef
    Hegedus, Balazs
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) : 1 - 18
  • [38] Tumor treating fields (TTFields) are effective for treatment of gastric cancer cells, boosting the activity of FOLFOX
    Flint-Brodsly, N.
    Zeevi, E.
    Fishman, H.
    Ene, H.
    Martinez-Conde, A.
    Frechtel-Gerzi, R.
    Wainer-Katsir, K.
    Dor-On, E.
    Porat, Y.
    Voloshin, T.
    Haber, A.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S49 - S49
  • [39] PI3Kα inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment
    Shi, Jia-jie
    Xing, Hui
    Wang, Yu-xiang
    Zhang, Xi
    Zhan, Qi-min
    Geng, Mei-yu
    Ding, Jian
    Meng, Ling-hua
    CANCER LETTERS, 2019, 459 : 145 - 155
  • [40] Inhibition of wildtype PI3Kα signaling is required for durable efficacy in PI3Kα mutant cancer cells due to robust reactivation of wild-type PI3Kα signaling
    MacDougall, John R.
    Zhong, Mengqi
    Merritt, Hanne
    Del Cid, Joselyn S.
    Bradley, John
    Mak, Raymond
    Dhawan, Neil
    Chen, Wei
    CANCER RESEARCH, 2023, 83 (07)
12345